Xuanxuan Zheng

Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations

Huijuan Wang, Ziqi Wang, Guowei Zhang et al. · Cancer Medicine · 2019 · 75 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy

Haixia Li, Chenyu Wang, Ziqi Wang et al. · Lung Cancer · 2019 · 28 citations

Medicine, Oncology, Pharmacology +12

Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study

Xiangtao Yan, Qiming Wang, Huijuan Wang et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 20 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Efficacy of first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) alone or in combination with chemotherapy for advanced non-small cell lung cancer (NSCLC) with low-abundance mutation

Xiangtao Yan, Huijuan Wang, Peng Li et al. · Lung Cancer · 2018 · 20 citations

Medicine, Oncology, Pharmacology +15

Mutation tracking of a patient with EGFR-mutant lung cancer harboring de novo MET amplification: Successful treatment with gefitinib and crizotinib

Xuanxuan Zheng, Guowei Zhang, Peng Li et al. · Lung Cancer · 2019 · 10 citations

Medicine, Oncology, Pharmacotherapy +17